BAYMIEV, A.K.,
KULUEV, B.R.,
SHVETS, K.Y.,
YAMIDANOV, R.S.,
MATNIYAZOV, R.T.,
CHEMERIS, D.A.,
IVANENKOV, Y.A.,
CHEMERIS, A.V.,
ZUBOV, V.V.,
ALEKSEEV, Y.I.,
MAVZYUTOV, A.R. (2020) to be preferable for the purpose. For other methods, the targets are directly
RNA molecules or their cDNA copies
Markelov, V.A.,
Korytina, G.F.,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N. Sh. (2024) of lnc
RNA (TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Ahmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) RNAs with implications toward the onset of cancer metastasis. LncRNAs FOXD2-AS1, KRT19P3 and the NF-κB interacting lnc
RNAMarkelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) of lnc
RNA (TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) to construct DCM model in wild-type and MD2 knockout mice. The collected heart samples were subjected to
RNA